Web Search: Goods Information jobs Download

        新闻分类
        Your present location:新闻首页 >> News >> Company news >> SyncoZymes successfully make intermediate of Ibrutinib on commercial production

        Font Size:big  middle  small

        SyncoZymes successfully make intermediate of Ibrutinib on commercial production

        Number of visits: Date:2014年4月28日 16:18

        After one year R&D, SyncoZymes become the first company in China that can make intermediate of Ibrutinib, (S)-1-Boc-3-hydroxypiperidine (CAS: 143900-44-1) on commercial production by enzymatic synthesis route. 

        TypeInfo: Company news

        Keywords for the information: